AQST FY 2021 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$51M+10.9% YoY

Gross Profit

$36M70.5% margin

Operating Income

-$35M-68.2% margin

Net Income

-$71M-138.8% margin

EPS (Diluted)

$-1.85

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$62M

Total Liabilities

$144M

Stockholders' Equity

-$82M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$46M	+10.9%
Gross Profit	$36M	$33M	+9.0%
Operating Income	-$35M	-$43M	+19.1%
Net Income	-$71M	-$56M	-26.5%